Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Corcept Therapeutics (CORT) Q4 2021 Earnings Call Transcript
06:00am, Wednesday, 16'th Feb 2022 The Motley Fool
CORT earnings call for the period ending December 31, 2021.
Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff On Q4 2021 Results - Earnings Call Transcript
01:56am, Wednesday, 16'th Feb 2022 Seeking Alpha
Corcept Therapeutics (CORT) Q4 Earnings Beat Estimates
10:55pm, Tuesday, 15'th Feb 2022 Zacks Investment Research
Corcept (CORT) delivered earnings and revenue surprises of 18.18% and 2.32%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Corcept Therapeutics Incorporated 2021 Q4 - Results - Earnings Call Presentation
09:58pm, Tuesday, 15'th Feb 2022 Seeking Alpha
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate Update
09:05pm, Tuesday, 15'th Feb 2022 GlobeNewswire Inc.
MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial stage company engaged in the discovery, development and sale of drugs to treat se
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate Update
09:05pm, Tuesday, 15'th Feb 2022 GlobeNewswire
MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial stage company engaged in the discovery, development and sale of drugs to treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol, today reported its results for the quarter and year ended December 31, 2021.
Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q4 2021 Results - Earnings Call Transcript
08:56pm, Tuesday, 15'th Feb 2022
Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q4 2021 Results - Earnings Call Transcript
Corcept Therapeutics (CORT) Q4 Earnings Beat Estimates
07:15pm, Tuesday, 15'th Feb 2022
Corcept (CORT) delivered earnings and revenue surprises of 18.18% and 2.32%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
01:38pm, Tuesday, 15'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage Bladder, Thyroid Cancer
Corcept Therapeutics Q4 2021 Earnings Preview
10:35pm, Monday, 14'th Feb 2022 Seeking Alpha
Corcept Therapeutics (NASDAQ:CORT) is scheduled to announce Q4 earnings results on Tuesday, Feb. 15, after market close.The consensus EPS estimate is $0.35
Is a Surprise Coming for Corcept (CORT) This Earnings Season?
01:48pm, Friday, 11'th Feb 2022 Zacks Investment Research
Corcept (CORT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Surprise Coming for Corcept (CORT) This Earnings Season?
10:00am, Friday, 11'th Feb 2022
Corcept (CORT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call
09:05pm, Tuesday, 08'th Feb 2022 GlobeNewswire Inc.
MENLO PARK, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2021 financial results and provide
Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference Call
09:05pm, Tuesday, 08'th Feb 2022 GlobeNewswire
MENLO PARK, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2021 financial results and provide a corporate update on February 15, 2022. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
05:10pm, Thursday, 03'rd Feb 2022 Zacks Investment Research
Corcept (CORT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
